Recommended Talks:

2nd Env Manufacturing Workshop
Choosing the right protein
September 2016
Hans Langedijk, Janssen, J&J
2nd Env Manufacturing Workshop
Case study of formulating protein for P5
September 2016
Antu Dey, International AIDS Vaccine Initiative (IAVI)
Product Development Boot Camp
Preclinical data and regulatory considerations
November 2015
Jim Ackland, Global Biosolutions
2nd Workshop on Prevention Trials in Infants Born to HIV-Positive Mothers
bNAbs development in infants
February 2017
Philip Goulder, Oxford University
No Monkey Business: Nonhuman Primate Models for HIV Prevention
October 2017
Co-Chair
Shelby O’Connor, University of Wisconsin
Matt Reynolds, University of Wisconsin
Introduction
Bargavi Thyagarajan, Global HIV Vaccine Enterprise
Non-human primate models of HIV maternal and infant immunization
Genevieve Fouda, Duke Human Vaccine Institute
Passive transfer of a single V2 monoclonal antibody reduces viral reservoirs in macaques during repeated SHIV challenges
Ann Hessell, Oregon Health & Science University
Tracking fluorophore-conjugated VRC01 following intravenous injection in the rhesus macaque
Jeffrey Schneider, Northwestern University
CyCMV vaccination induces unconventional CD8 T cells in mauritian cynomolgus macaques
Justin Greene, Oregon Health & Science University
Moderator
Shelby O’Connor, University of Wisconsin
Matt Reynolds, University of Wisconsin
Panelist
Genevieve Fouda, Duke Human Vaccine Institute
Ann Hessell, Oregon Health & Science University
Jeffrey Schneider, Northwestern University
Justin Greene, Oregon Health & Science University

Search:

Search term(s):

Search for text in:

separate each search
term with a space

Multiple terms:

Conference Years:

Content Type:

Latest Additions

Meeting Format: 2 hour webinar   |   October 2017
The webcast featured presentations covering the uses and limitations of various approaches and data inputs of model-based analysis pertinent to HIV vaccine research followed by a panel discussion. Webcasts | Learn More
Meeting Format: 3 day meeting   |   October 2017
A webcast featuring several of the presentations of the 2017 Cent Gardes meeting, addressing a range of topics pertinent to HIV vaccine research Webcasts | Learn More
Meeting Format: 1.5 hour webinar   |   October 2017
The webinar presented four pathbreaking studies using NHP models to test active and passive immunization approaches for HIV prevention followed by a panel discussion. Webcasts | Learn More
Meeting Format: 1.5 day meeting   |   July 2017
The third annual workshop brought together experts to discuss advances in manufacturing of recombinant HIV Env protein, with special focus on the challenges production for early stage clinical trials. Webcasts | Learn More
Meeting Format: Video Recordings   |   July 2017
The IAS 2017 satellite, "Future Perfect," explored the latest in HIV vaccine design, development, and testing, with a focus on current trials on an efficacy pathway and promising approaches in pre- or early clinical trials. Webcasts | Learn More
Meeting Format: 2 day meeting   |   May 2017
The workshop brought together imaging experts from inside and outside the HIV/SIV field to discuss the strengths, limitations and applications of emerging imaging technologies in HIV/SIV research. Webcasts | Learn More
Meeting Format: Video Recordings   |   March 2017
The ePanel and SciTalks addressed a broad range of topics pertinent to state-of-the-art HIV vaccine research. Webcasts | Learn More
Meeting Format: 1.5 day meeting   |   February 2017
This meeting convened key experts to discuss the conduct of efficacy trials of potential new immune-based approaches to interrupt MTCT of HIV. Webcasts | Learn More
Meeting Format: Video Recordings   |   November 2016
The ePanel and SciTalks addressed a broad range of topics pertinent to state-of-the-art HIV vaccine research. Webcasts | Learn More
Meeting Format: 4 hour meeting   |   October 2016
An interactive session at HIVR4P 2016 to discuss HIV research capacity strengthening in Africa and to launch AAVVi.net. Scientists, advocates and policy makers share success stories, identify gaps, challenges and opportunities. Webcasts
1 2 3